|By Business Wire||
|August 18, 2014 12:40 PM EDT||
Research and Markets (http://www.researchandmarkets.com/research/53xwbk/global) has announced the addition of the "Global Regenerative Medicines Market (Technology, Application and Geography) - Size, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering.
According to a new market research report titled, "Global Regenerative Medicine Market (Technology, Applications, Geography) - Industry Analysis, Trends, Opportunities and Forecast, 2013-2020", the global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.
Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines, which are palliative. The immense potential of these medicines in repairing or regenerating diseased organs is the major reason for intensive focus on research and development in this field. The technologies implemented for these medicines utilize various cell types including stem cells. The advancements in nanotechnology and stem cells application would account for further progress of this novel field of medicine. The global regenerative medicine market is segmented based on technologies into small molecules and biologics, gene therapy and cell therapy.
Key Topics Covered:
CHAPTER 1. INTRODUCTION
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. GLOBAL REGENERATIVE MEDICINES MARKET OVERVIEW
CHAPTER 4. GLOBAL REGENERATIVE MEDICINE MARKET BY TECHNOLOGIES
CHAPTER 5. GLOBAL REGENERATIVE MEDICINE MARKET BY APPLICATIONS
CHAPTER 6. GLOBAL REGENERATIVE MEDICINES MARKET BY GEOGRAPHY
CHAPTER 7. COMPANY PROFILES
- Advanced Cell Technology
- Athersys Inc.
- Cytori Therapeutics
- Kinetic Concepts
- Mesoblast Ltd.
- Shire pharmaceuticals
- Stem Cells
For more information visit http://www.researchandmarkets.com/research/53xwbk/global
May. 28, 2016 05:00 AM EDT Reads: 3,187
May. 28, 2016 05:00 AM EDT Reads: 2,062
May. 28, 2016 04:15 AM EDT Reads: 3,162
May. 28, 2016 03:00 AM EDT Reads: 2,496
May. 28, 2016 03:00 AM EDT Reads: 1,299
May. 28, 2016 02:30 AM EDT Reads: 778
May. 28, 2016 01:30 AM EDT Reads: 1,436
May. 28, 2016 01:15 AM EDT Reads: 1,265
May. 28, 2016 01:00 AM EDT Reads: 1,916
May. 28, 2016 01:00 AM EDT Reads: 1,246
May. 28, 2016 12:45 AM EDT Reads: 1,320
May. 28, 2016 12:30 AM EDT Reads: 2,008
May. 28, 2016 12:15 AM EDT Reads: 2,414
May. 28, 2016 12:00 AM EDT Reads: 1,325
SYS-CON Events announced today that EastBanc Technologies will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. EastBanc Technologies has been working at the frontier of technology since 1999. Today, the firm provides full-lifecycle software development delivering flexible technology solutions that seamlessly integrate with existing systems – whether on premise or cloud. EastBanc Technologies partners with p...
May. 27, 2016 11:30 PM EDT Reads: 2,305